Cargando…
High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel
Breast cancer has become the leading cause of cancer-related death among women. A large number of patients become resistant to drug chemotherapy. Paclitaxel (Taxol) is an effective chemotherapeutic agent used to treat cancer patients. Taxol has been widely used in human malignancies including breast...
Autores principales: | Luo, Yanwei, Wang, Xinye, Wang, Heran, Xu, Yang, Wen, Qiuyuan, Fan, Songqing, Zhao, Ran, Jiang, Shihe, Yang, Jing, Liu, Yukun, Li, Xiayu, Xiong, Wei, Ma, Jian, Peng, Shuping, Zeng, Zhaoyang, Li, Xiaoling, Phillips, Joshua B., Li, Guiyuan, Tan, Ming, Zhou, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583467/ https://www.ncbi.nlm.nih.gov/pubmed/26406239 http://dx.doi.org/10.1371/journal.pone.0138955 |
Ejemplares similares
-
Bromodomain-containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2-antagonist/killer protein
por: Ma, Jinqi, et al.
Publicado: (2019) -
BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
por: Niu, Weihong, et al.
Publicado: (2018) -
p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild‐type p53
por: Zhou, Yao, et al.
Publicado: (2019) -
BRD7 Stabilizes P53 via Dephosphorylation of MDM2 to Inhibit Tumor Growth in Breast Cancer Harboring Wild-type P53
por: Luo, Yanwei, et al.
Publicado: (2022) -
Retraction Note: BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
por: Niu, Weihong, et al.
Publicado: (2019)